ASCO: Larotrectinib Produces Durable Responses
TRK fusion targets multiple cancers Patients diagnosed with a variety of advanced cancers —...
Read More
Hematology/Oncology
ASCO: Survival Benefit Emerges in ARAMIS
Darolutamide better in non-metastatic castration-resistant prostate cancer Men diagnosed with...
Read More
ASCO: Consultant Palliation Improves AML Quality of Life
Early referral linked to better psychological outcomes Referring a patient diagnosed with acute...
Read More
ASCO: Gastric Cancer Patients Respond to Trastuzumab Deruxtecan
Overall survival also extended with conjugate treatment In a small, phase II trial, patients with...
Read More
ASCO: Oral GnRH Antagonist Superior to Leuprolide Injection in Prostate Cancer
HERO findings also confirm fewer cardiovascular events with relugolix More than 96% of men with...
Read More
Insulin Resistance May Add to Racial Disparity in Breast Cancer Prognosis
MONDAY, June 1, 2020 (HealthDay News) — Insulin resistance is one factor mediating part of...
Read More
Radiation Oncology Clinic Visits Down Due to COVID-19
MONDAY, June 1, 2020 (HealthDay News) — Despite adoption of enhanced safety measures,...
Read More
Mortality Rate 13% for Cancer Patients with COVID-19
MONDAY, June 1, 2020 (HealthDay News) — For patients with cancer and COVID-19, mortality is...
Read More
Infection Risk Up in Month After CAR T-Cell Immunotherapy
FRIDAY, May 29, 2020 (HealthDay News) — For children and young adults receiving CD19...
Read More
Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers
FRIDAY, May 29, 2020 (HealthDay News) — For adolescent and young adult (AYA) patients with...
Read More
ASCO 2020: Relugolix Superior to Leuprolide in Advanced Prostate Cancer
FRIDAY, May 29, 2020 (HealthDay News) — For men with advanced prostate cancer, the oral...
Read More
Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services
WEDNESDAY, May 27, 2020 (HealthDay News) — In 2018, half of U.S. hospitals had the capacity...
Read More
Early Informed Lung Cancer Patients Have Greater Survival Rates
WEDNESDAY, May 27, 2020 (HealthDay News) — Lung cancer patients who are given the...
Read More
Conference Highlights: AATS 2020
New research was presented at AATS 2020, the virtual Annual Meeting of the American Association...
Read More
Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects
TUESDAY, May 26, 2020 (HealthDay News) — For patients with advanced-stage pancreatic ductal...
Read More
Lasting Drop Seen in CRC Incidence, Death After Negative Colonoscopy
TUESDAY, May 26, 2020 (HealthDay News) — Colorectal cancer (CRC) incidence and mortality are...
Read More
Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening study.
ATP citrate lyase (ACLY) is an important enzyme that catalyzes the conversion of citrate to...
Read More
Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer.
The mitochondrial fission protein, Dynamin related protein 1 (Drp1), and its upstream protein...
Read More
Sentinel lymph node technique in early-stage ovarian cancer: a phase II clinical trial.
Early-stage ovarian cancer might represent an ideal disease scenario for sentinel lymph node...
Read More
Loss of 4.1N in epithelial ovarian cancer results in EMT and matrix-detached cell death resistance.
Epithelial ovarian cancer (EOC) is one of the leading causes of death from gynecologic cancers and...
Read More